Skip to main content
Caplight Logo









CDx Diagnostics

CDx Diagnostics

Private
Suffern, New YorkHealthcare & Life Scienceshttps://www.cdxdiagnostics.com/

Last Round

VC Round

Dec 1, 2019

Total Funding Raised

$60M

Company Overview

CDx Diagnostics is a healthcare company that provides specialized anatomic pathology laboratory services and AI-powered diagnostic technology for the early detection of precancerous and cancerous tissue.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

anatomic pathologyWATS3Ddigital pathologyprecancerous detectionpathology labbrush biopsyesophageal cancer screeningAI diagnosticsAI pathologycancer screening techCLIA-certified laboratoryCAP-accreditedcytologyimmunohistochemistryhistology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CDx Diagnostics Comparables

Compare CDx Diagnostics with similar companies based on industry and business-model similarity.

CDx Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lucid Diagnostics Inc.
78%
Castle Biosciences, Inc.
77%
ProPhase Labs Inc
71%

CDx Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2019
Private EquityJul 11, 2017
DebtJul 11, 2017

Key People

Founding team and executive leadership

Mark Rutenberg

Founder and Chief Scientific Officer, Founder

Founding Team

Edward Yom

Senior Vice President, Chief Technology Officer

Executive Team

CDx Diagnostics Investors

Notable investors and investment history

CDx Diagnostics investors
InvestorRounds
Galen PartnersPrivate Equity
White Oak Healthcare FinanceDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Monthly visitors increased 47% MoM.

  • Jul 11, 2017

    $40M round led by Galen Partners.

CDx Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CDx Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CDx Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuffern, New York
Employee Range122
Year Founded1997
Last FundingDec 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.